Comparison of combinations of drugs for treatment of obesity: body weight and echocardiographic status.

Whigham, L D; Dhurandhar, N V; Rahko, P S; Atkinson, R L

Whigham, L D; Dhurandhar, N V; Rahko, P S; Atkinson, R L.

Affiliation

Whigham LD; Department of Medicine, University of Wisconsin, Madison, WI, USA.

Int J Obes (Lond) ; 31(5): 850-7, 2007 May.

Article in En | MEDLINE | ID: mdl-17146452

Subject(s)

Appetite Depressants/therapeutic use; Fenfluramine/therapeutic use; Fluoxetine/therapeutic use; Obesity/drug therapy; Phentermine/therapeutic use; Selective Serotonin Reuptake Inhibitors/therapeutic use; Adult; Appetite Depressants/administration & dosage; Appetite Depressants/adverse effects; Body Mass Index; Drug Therapy, Combination; Fenfluramine/administration & dosage; Fenfluramine/adverse effects; Fluoxetine/administration & dosage; Fluoxetine/adverse effects; Heart Valve Diseases/chemically induced; Heart Valve Diseases/diagnostic imaging; Humans; Medical Records; Phentermine/administration & dosage; Phentermine/adverse effects; Retrospective Studies; Selective Serotonin Reuptake Inhibitors/administration & dosage; Selective Serotonin Reuptake Inhibitors/adverse effects; Ultrasonography; Weight Loss/drug effects

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Appetite Depressants / Phentermine / Fluoxetine / Selective Serotonin Reuptake Inhibitors / Fenfluramine / Obesity Type of study: Diagnostic_studies / Observational_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Int J Obes (Lond) Year: 2007 Document type: Article

Search on Google

XML

PubMed Links